Ernestine Harte

Director, Quality Assurance at Faraday Pharmaceuticals

Ernestine Harte has over 28 years of experience in the pharmaceutical industry. Ernestine began their career in 1993 as a Quality Control Associate II at Praxis Biologics (Lederle Praxis; Wyeth Lederle; Wyeth). In 2002, they joined Argos Therapeutics, Inc. (NASDAQ: ARGS) as Supervisor, QA Document Control. In 2011, they moved to Chimerix, Inc., where they held the roles of QA Document Specialist, QA Manager, and Associate Director, QA Quality Systems. In 2019, Harte joined LottieEllis Quality Compliance as Quality Assurance and Strategic Compliance Consultant. In 2021, they began working for Jaguar Health as Director, Quality Assurance and Sr. Manager Quality Assurance. Harte currently holds the role of Director, Quality Assurance at Faraday Pharmaceuticals, Inc.

Ernestine Harte has a Master of Science Technology Systems (MSTS) with a Quality Systems concentration from East Carolina University and a B.S in Organizational Management from Saint Augustine's University. Ernestine also holds a Lean Six Sigma Black Belt Certification from East Carolina University obtained in May 2018, a Certified Quality Improvement Associate from ASQ - World Headquarters obtained in January 2001, and a MasterControl Master Certification.

Location

Raleigh, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Faraday Pharmaceuticals

Faraday Pharmaceuticals' mission is to improve the quality of life for patients after acute critical illness by minimizing damage to cardiac and skeletal muscle.


Industries

Employees

11-50

Links